14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.91 $2.71 Wednesday, 24th Apr 2024 CANF stock ended at $1.94. This is 1.52% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 1.03% from a day low at $1.94 to a day high of $1.96.
90 days $1.91 $2.71
52 weeks $1.71 $3.33

Historical Can-Fite BioPharma Ltd prices

Date Open High Low Close Volume
Mar 19, 2024 $2.20 $2.23 $2.17 $2.18 8 338
Mar 18, 2024 $2.14 $2.20 $2.04 $2.19 15 338
Mar 15, 2024 $2.17 $2.17 $2.12 $2.12 2 100
Mar 14, 2024 $2.25 $2.25 $2.10 $2.14 11 853
Mar 13, 2024 $2.14 $2.24 $2.13 $2.24 5 490
Mar 12, 2024 $2.24 $2.25 $2.11 $2.14 8 387
Mar 11, 2024 $2.20 $2.25 $2.16 $2.25 19 257
Mar 08, 2024 $2.17 $2.25 $2.16 $2.21 30 239
Mar 07, 2024 $2.12 $2.20 $2.10 $2.16 37 020
Mar 06, 2024 $2.20 $2.20 $2.10 $2.13 19 549
Mar 05, 2024 $2.13 $2.14 $2.04 $2.10 12 418
Mar 04, 2024 $2.06 $2.14 $2.04 $2.14 13 015
Mar 01, 2024 $2.16 $2.16 $2.07 $2.13 13 034
Feb 29, 2024 $2.12 $2.14 $2.09 $2.14 6 559
Feb 28, 2024 $2.06 $2.15 $2.06 $2.08 61 710
Feb 27, 2024 $2.10 $2.10 $2.02 $2.10 24 968
Feb 26, 2024 $2.06 $2.10 $2.06 $2.10 28 130
Feb 23, 2024 $2.10 $2.18 $2.06 $2.06 68 242
Feb 22, 2024 $2.06 $2.10 $2.06 $2.10 12 350
Feb 21, 2024 $2.08 $2.08 $2.03 $2.05 15 943
Feb 20, 2024 $2.04 $2.09 $2.00 $2.07 7 036
Feb 16, 2024 $2.10 $2.10 $2.05 $2.08 5 202
Feb 15, 2024 $2.06 $2.15 $2.06 $2.10 9 393
Feb 14, 2024 $2.04 $2.09 $2.04 $2.04 7 774
Feb 13, 2024 $2.02 $2.04 $2.02 $2.03 10 900
Click to get the best stock tips daily for free!

About Can-Fite BioPharma Ltd

Can-Fite BioPharma Ltd Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical tria... CANF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT